Boston BioBreak – Events Archive
Please see below for attendees and images from this event.
Boston
Boston BioBreak Networking Happy Hour- March 22nd, 2018
March 22, 2018
5:30-7:30 pm
Attendees at this event
Geoff Meyerson | Locust Walk |
Jamil Beg | 5AM Ventures |
Peter Lanciano | Periphagen Inc. |
Jay Mohr | Dirigo Therapeutics |
Jordan Leef | Pyramid Biosciences Inc |
Donald Fishbein | Evolve Therapeutics |
Imran Eba | Action Potential Venture Capital |
Brian Gallagher | SR One |
Imran Nasrullah | Boehringer-Ingelheim |
Greg Miller | Visterra |
Brad Prosek | Constellation Pharmaceuticals |
Yukari Perrella | Yuma Therapeutics |
Kleem Chaudhary | Biogen |
Marcelo Cheresky | Bioverativ |
Paul Conrad | Bluebird Bio |
Douglas MacDougall | MacDougall Biomedical Communications |
Catherine Thut | Novartis Institutes for BioMedical Research |
Bonnie Fendrock | Cyta Therapeutics |
Brad Carver | SynDevRx |
John Hennessy | Palleon Pharmaceuticals Inc |
Rick Lundberg | Navitor Pharmaceuticals |
Bob Silverman | Roche |
Paul Juniewicz | Takeda Oncology |
Alan Kugler | Coastal Pharma Group |
Eric Elenko | PureTech Ventures |
Jonathan Behr | JDRF T1D Fund |
Christine Bunt | 20/20 Health Care Partners |
Michal Preminger | Harvard University |
David Brush | Johnson & Johnson |
Caleb Moore | Acceleron Pharma |
Gordon Jamieson | Translational Therapeutics |
Kathryn Gregory | Shire Pharmaceuticals |
Barbara Fox | Tilos Therapeutics |
Laurence Reid | Warp Drive Bio |
Mark Fraga | Life Sciences |
John Dunlop | Amgen |
Steven Tregay | FORMA Therapeutics |
Avi Spier | Novartis |
John Schwartz | AcuityBio |
Jeff Imbaro | Semma Therapeutics |
Ed Mascioli | EMMD LLC |
Arthur Hiller | Antyllus Therapeutics |
Scott Edwards | SciFluor Life Sciences |
Markus Haeberlein | Alkermes |
Martin Williams | Yuma Therapeutics Corp |
Marian Nakada | J&J |
Geoffrey Horwitz | Decibel Therapeutics |
Grant Zimmermann | Harvard University |
Andy Meyerson | Locust Walk |
Brendan Downey | Takeda |
Michael Boretti | Epizyme |
Ryan Dietz | Boston Children's Hospital |
John Tagliamonte | WntRx |
Baruch Harris | Fidelity Biosciences |
John Delyani | Merck |
Tariq Kassum | Obsidian |
Chuck Kunsch | AbbVie Ventures |
Neil Swami | MVM Life Sciences Partners |
Martin Heidecker | Boehringer Ingelheim Venture Fund |
James Shanahan | SynDevRx, Inc. |
Alexander Pickett | Mediqventures, Ltd. |
Rich Howlett | Keros Therapeutics |
Bob Palladino | Bionevia LLC |
Josh Hamermesh | Locust Walk |
Catherine Sohn | Jazz Pharmaceuticals |
Tom Fitzgerald | Velico Medical, Inc. |
Lizabeth Leveille | Merck |
Laura Sepp-Lorenzino | Vertex Pharmaceuticals |
Ailis Tweed-Kent | Cocoon Biotech |
David Standring | |
Brian Hess | LaunchPad Medical |
Anupama Ahuja | Children's TIDO |
Mustafa Noor | Akcea Therapeutics |
Maude Tessier | Merck |
Roman Fleck | Janpix |
Stephen Potter | AGTC |
Neal Farber | NEUROHEALING PHARMACEUTICALS |
Derek Yoon | AJU IB Investment |
Patrick Tricoli | NANOBIOTIX US |
Chris Primiano | Karyopharm Therapeutics |
Andrew meadow | Excelyrate Capital |
Kyle Meetze | EdenRoc Sciences |
Fumitaka Mori | Remiges Ventures |
Michael Magliochetti | Riverside Partners |
Tarik Soliman | Extend Biosciences |
Joel Batson | RA Capital Management |
Chris Gemmiti | Sentien Biotech |
Jennifer Wheler | Novartis |
Phillip Samayoa | Atlas Ventures |
Catherine Nuccio | Alexandria Venture Investments |
Remis Bistras | ThermoPharma |
Shaan Gandhi | Longwood Fund |
Weijie Poh | PathoVax |
Christopher Scannell | Akrivis |
Stephen Curtis | MPM Capital |
Anh Hoang | Sofregen Medical |
Daniel Macaya | RA capital |
Ted Marple | Acworth Pharmaceuticals, Inc. |
David Sherris | GenAdam Therapeutics |
Joel BERNIAC | Akrivis Technologies |
Meredith Fisher | Partners Innovation Fund |
Bruce Beutel | SQZ Biotech |
Amanda Kay | Synlogic |
Hhilippe Mauberna | Nanobiotix |
Kollol Pal | Pyramid Biosciences |
Laurent Levy | Nanobiotix |
Connor Duffy | Draper Nexus Ventures |
Patrice Milos | Medley Genomics |
Kevin Mills | Cyteir Therapeutics, Inc |
Edwin Holland | Cenoxsys, LLC |
Yury Kukushkin | 4biocapital |
Kate Rumrill | NeoSync, Inc. |
Gary Fletcher | SphereVis |
Peng Leong | Novogen |
John M Sorvillo | ReForm Biologics |
Stefano Gulla | Abcuro |
Howard Kim | Asahi Kasei |
Maria Zlyhastseva | BioBreak |
David Raiser | Aldatu Biosciences |
Jennifer King | Intellia Therapeutics |
Kevin Pong | Summit Therapeutics |
Alan Ginsberg | Shire |
Ram Aiyar | Corvidia Therapeutics |
Anthony Walsh | RA Capital LLC |
Bryan Lord | Orthopedic Venture Partners |
Bill Whelan | Mintz Levin |
Laura Stoppel | RA Capital Management |
Meg Krench | RA Capital Management |
William Korinek | Astrocyte Pharmaceuticals |
Adi Mashiach | Mesia Ventures |
Michael Dudley | TransCode Therapeutics, Inc. |
Wendy Nelson | Transcode Therapeutics |
Eric Evans | Mass Medical Angels |
Evan Thompson | Abcuro |
Daniel Seto | SternAegis Ventures |
Komal Joshi | Jounce Therapeutics |
Jack Leonard | Acworth Pharmaceuticals, Inc |
VIPULA TAILOR | Azure8 |
Vito Palombella | Surface Oncology |
Larry Cai | Qilu |
Jason Ruth | 5AM Ventures |
Kathryn McCabe | Eli Lilly |
Nevin M. Summers | MIT Synthetic Biology Center |
Benjamin Sigel | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
Kerrie Brady | Cetrexion Therapeutics |
Victor Shifrin | ImmunoChem Therapeutics |
Joep Muijrers | LSP Life Sciences Partners |
Rajeev Chillakuru | Boston Pharmaceuticals |
Joseph Lobacki | Crestovo LLC |
Jin Ji | PulchriBio |
Arkesh Mehta | OncoBindi Therapeutics |
Thomas Leggett | Axcella Health |
Sophie de Boer | Flagship Pioneering |
Julien Pham | Genprex |
Reza Mazhari | Novartis Institutes for BioMedical Research |
Maria Palasis | 480 Biomedical, Inc. |
John Dellapa | Mintz Levin |
Anna French | Qiming Venture US |
Rosy Hu | Partners Innovation Fund |
Laszlo Kiss | Pfizer |
Isabella Zhang | JDRF T1D Fund |
Melissa BradfordKlug | Keryx |
Brian DeSchuytner | TESARO |
Erika Bechtold | Sofregen Medical |
James Jogerst | Berg Health |
Adam Buckley | VBI Vaccines Inc |
Ravneesh Sachdev | Bioverativ |
Kathryn McAllister | Amgen |
Fred Chereau | LogicBio |
Rakhshita Dhar | Roche |
Seiji Nakano | Asahi Kasei - Healthcare |
John Parker | Springhood Impact Ventures |
Kyle Dempsey | MVM Partners |
Frank Haluska | BioCanCell |
Magdalene Moran | Hydra Biosciences |
Angelo Moesslang | InGeneron |
Andrew Gengos | Synlogic |
Mark Barrett | Frazier Healthcare |
Marc Schwabish | Fusion Pharma |
Yoshiaki Kato | Kissei America Inc. |
Martin Tolar | Alzheon |
Paul Jaminet | Angiex Inc |
Mark Charest | Phenomic Capital |
Joerg Holenz | GSK |
Albert Hsia | Merck |
Alex Ray | Boston Millennia Partners |
Sabrina Yang | Flagship Pioneering |
Ben Davis | AngioDynamics |
Thomas Collet | Phrixus Pharmaceuticals, Inc. |
Timothy Salmon | Socium Therapeutics, Inc. |
Theonie Anastassiadis | Flagship Pioneering |
Luba Greenwood | |
Benjamin Kreitman | Broadview Ventures |
Tiffany Yu | F-Prime Capital |
Alan Kriz | Bayer US |
Mike Luther | Bantam Pharmaceutical, LLC |
Rene Castro | Foundation Medicine |
Jeanne Bertonis | Visgo |
David Tabaczynski | Phion Therapeutics Limited |
Rooz Riahi | RA Capital |
Christopher Gagliardi | Sanofi |
Oliver Dodd | Remora Therapeutics |
Melissa McCracken | Third Rock Ventures |
Photo Gallery for this event
Click any image to view slideshow
(no images found)
Become a Supporter
For more information about sponsorship, please email us at sponsorship@biobreak.org.